These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8072194)

  • 21. Prediction of aminoglycoside response against methicillin-resistant Staphylococcus aureus infection in burn patients by artificial neural network modeling.
    Yamamura S; Kawada K; Takehira R; Nishizawa K; Katayama S; Hirano M; Momose Y
    Biomed Pharmacother; 2008 Jan; 62(1):53-8. PubMed ID: 18083323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination therapy with arbekacin and fosfomycin against postoperative severe mixed-pneumonia of MRSA in primary lung cancer patients].
    Harada R; Miyamoto H; Sakao Y; Hamada T; Hata E
    Kyobu Geka; 1995 Sep; 48(10):836-40. PubMed ID: 7474582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
    Kobayashi Y
    Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of arbekacin for staphylococcal infection in the NICU.
    Suzuki K
    Pediatr Int; 2003 Jun; 45(3):301-6. PubMed ID: 12828585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genomic DNA fingerprinting of arbekacin-resistant MRSA by pulsed-field gel electrophoresis].
    Nonoyama M; Ida T; Hasobe T; Shimauchi C; Inoue M; Okamoto R; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):627-33. PubMed ID: 8072170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined effects of arbekacin with biapenem against in vitro and in vivo model of a mixture of MRSA and Pseudomonas aeruginosa].
    Niida M; Sakakibara S; Kawabata T; Maebashi K; Takata T; Hikida M
    Jpn J Antibiot; 2004 Jun; 57(3):288-93. PubMed ID: 15376787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Aug; 45(8):958-64. PubMed ID: 1433902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus].
    Watanabe T; Kanno M; Sobu K; Takase Y; Yoshida T
    Jpn J Antibiot; 1995 Feb; 48(2):284-92. PubMed ID: 7745817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1312-8. PubMed ID: 1479683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies of arbekacin sulfate in the pediatric field].
    Fujii R; Fujita K; Sakata Y; Abe T; Tajima T; Terashima I; Meguro H; Watanabe N; Mikuni K; Sakai T
    Jpn J Antibiot; 1994 Jan; 47(1):57-83. PubMed ID: 8114274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Special issue: Current state of MRSA infections and practical chemotherapy with arbekacin].
    Jpn J Antibiot; 1994 Jun; 47(6):561-843. PubMed ID: 8072164
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
    Lee DG; Chun HS; Yim DS; Choi SM; Choi JH; Yoo JH; Shin WS; Kang MW
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3768-73. PubMed ID: 14638480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
    Watanabe T; Sobu K; Takase Y; Kawabata T; Kanno M; Yoshida T
    Jpn J Antibiot; 1994 Jun; 47(6):701-9. PubMed ID: 8072178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
    Miyata A; Araake M; Ogawa H; Hanaki H; Hiramatsu K
    Jpn J Antibiot; 2001 Jul; 54(7):372-81. PubMed ID: 11560056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
    Tabata M; Shimizu M; Araake M; Ogawa H
    Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
    Suzuki T; Fujita K; Nagamachi Y; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):634-9. PubMed ID: 8072171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.